Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 15, 2009
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer
C Liedtke, K Broglio, S Moulder, et al.
Clinical & Experimental Metastasis
|
October 17, 2018
Systematic analysis of parameters predicting pathological axillary status (ypN0 vs. ypN+) in patients with breast cancer converting from cN+ to ycN0 through primary systemic therapy (PST)
C Liedtke, Hans-Christian Kolberg, L Kerschke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 30, 2016
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial
O Gluz, C Liedtke, J Huober, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel
U A Nitz, O Gluz, M Christgen, et al.
British Journal of Cancer
|
August 16, 2012
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial
I Witzel, S Loibl, G von Minckwitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 31, 2014
Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy
J L Lindner, S Loibl, C Denkert, et al.
Geburtshilfe Und Frauenheilkunde
|
July 14, 2015
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)
M Untch, N Harbeck, J Huober, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 15, 2009
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer
C Liedtke, K Broglio, S Moulder, et al.
Clinical & Experimental Metastasis
|
October 17, 2018
Systematic analysis of parameters predicting pathological axillary status (ypN0 vs. ypN+) in patients with breast cancer converting from cN+ to ycN0 through primary systemic therapy (PST)
C Liedtke, Hans-Christian Kolberg, L Kerschke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 30, 2016
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial
O Gluz, C Liedtke, J Huober, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel
U A Nitz, O Gluz, M Christgen, et al.
British Journal of Cancer
|
August 16, 2012
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial
I Witzel, S Loibl, G von Minckwitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 31, 2014
Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy
J L Lindner, S Loibl, C Denkert, et al.
Geburtshilfe Und Frauenheilkunde
|
July 14, 2015
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)
M Untch, N Harbeck, J Huober, et al.
Page
of 3